Jiang, W., Li, Q., Zhang, R., Li, J., Lin, Q., Li, J., . . . Fan, K. (2023). Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson’s disease. Nature communications, 14(1), 8137-18. https://doi.org/10.1038/s41467-023-43870-3
Chicago Style (17th ed.) CitationJiang, Wei, Qing Li, Ruofei Zhang, Jianru Li, Qianyu Lin, Jingyun Li, Xinyao Zhou, Xiyun Yan, and Kelong Fan. "Chiral Metal-organic Frameworks Incorporating Nanozymes as Neuroinflammation Inhibitors for Managing Parkinson’s Disease." Nature Communications 14, no. 1 (2023): 8137-18. https://doi.org/10.1038/s41467-023-43870-3.
MLA (9th ed.) CitationJiang, Wei, et al. "Chiral Metal-organic Frameworks Incorporating Nanozymes as Neuroinflammation Inhibitors for Managing Parkinson’s Disease." Nature Communications, vol. 14, no. 1, 2023, pp. 8137-18, https://doi.org/10.1038/s41467-023-43870-3.